Apr 1, 1991

Management of hypertension by reduction in sympathetic activity

Hypertension
C J Mathias

Abstract

The sympathetic nervous system may initiate or maintain hypertension, and a range of approaches that reduce sympathetic activity is often of value in management. These may include nonpharmacological methods, such as the various forms of behavioral therapy (e.g., meditation, relaxation, and biofeedback techniques); weight reduction and avoidance of particular foods and agents that stimulate sympathetic activity (including caffeine and alcohol), and regular physical exercise. Pharmacological therapy includes centrally acting drugs such as alpha-methyldopa, clonidine, and reserpine; ganglionic blockers such as hexamethonium; agents acting on sympathetic nerve terminals such as guanethidine and debrisoquine; and drugs that may act at multiple sites, such as the beta-adrenergic blockers. The role of reducing sympathetic activity in the current management of hypertension and its complications is considered in this overview.

  • References
  • Citations11

References

  • We're still populating references for this paper, please check back later.

Mentioned in this Paper

DRUG Screen Quant Caffeine
Debrisoquin
Sympathetic Nervous System
Diastolic Blood Pressure
Sembrina
Biological Feedback
Entire Sympathetic Nervous System
Guanethidine
Hypertensive Disease
Hexamethonium

About this Paper

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society
J J van LieshoutJ M Karemaker
© 2020 Meta ULC. All rights reserved